News Industry News ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease October 12, 2015
News Industry News ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes October 12, 2015
News Conference News TCT 2015 ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years October 12, 2015
News Daily News Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores Todd Neale October 08, 2015
News Daily News La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia Todd Neale October 08, 2015
Presentation Medical Therapy vs Revascularization for StableCAD Pts With Unclassified Appropriateness Score Presenter: M. Shuvy October 07, 2015
News Industry News Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System October 05, 2015
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Daily News No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES Yael L. Maxwell August 26, 2015
News Daily News Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI L.A. McKeown August 05, 2015
News Daily News In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year Yael L. Maxwell July 31, 2015
News Daily News COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años Salynn Boyles July 30, 2015